{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:35:11Z","timestamp":1791200111097,"version":"4.2.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cell Biology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ejcb.2011.09.011","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T09:11:18Z","timestamp":1323940278000},"page":"139-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target"],"prefix":"10.1016","volume":"91","author":[{"given":"Clara","family":"Crescioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Sottili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Cosmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Chiarugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Romagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella B.","family":"Vannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Colletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Isidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Serio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Di Luigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejcb.2011.09.011_bib0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1083\/jcb.132.4.657","article-title":"Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis","volume":"132","author":"Andr\u00e8s","year":"1996","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/eje.1.02137","article-title":"Increased serum CXCL10 in Graves\u2019 disease or autoimmune thyroiditis is associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process","volume":"154","author":"Antonelli","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0015","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1210\/jc.2005-1689","article-title":"Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves\u2019 ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"91","author":"Antonelli","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0020","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cellbi.2008.11.015","article-title":"Pax3 and Pax7 expression during myoblast differentiation in vitro and fast and slow muscle regeneration in vivo","volume":"33","author":"Brz\u00f3ska","year":"2009","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1096\/fj.02-0908fje","article-title":"Allergic humans are hypo-responsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop","volume":"18","author":"Campbell","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0030","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.emboj.7600958","article-title":"Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters","volume":"25","author":"Cao","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0035","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#","article-title":"CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease","volume":"30","author":"Cosmi","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1677\/JOE-07-0240","article-title":"Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes","volume":"195","author":"Crescioli","year":"2007","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0045","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.yexcr.2007.12.016","article-title":"Immunosuppression in cardiac graft rejection: a human in vitro model to study the potential use of new immunomodulatory drugs","volume":"314","author":"Crescioli","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0050","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0055","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1471-4892(01)00053-4","article-title":"The molecular and cellular pathology of inflammatory muscle diseases","volume":"1","author":"Dalakas","year":"2001","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0060","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/j.lpm.2011.01.005","article-title":"Pathophysiology of inflammatory and autoimmune myopathies","volume":"40","author":"Dalakas","year":"2011","journal-title":"Presse Med."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0065","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00401-005-0989-5","article-title":"Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies","volume":"109","author":"De Paepe","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1196\/annals.1398.050","article-title":"Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses","volume":"1109","author":"De Paepe","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0075","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.2741\/2866","article-title":"Chemokines in idiopathic inflammatory myopathies","volume":"13","author":"De Paepe","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0080","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/BOR.0b013e3283317b31","article-title":"Role of cytokines and chemokines in idiopathic inflammatory myopathies","volume":"21","author":"De Paepe","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0085","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/intimm\/12.9.1329","article-title":"Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation","volume":"12","author":"De Rossi","year":"2000","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0090","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1517\/14712598.4.4.443","article-title":"Embryonic committed stem cells as a solution to kidney donor shortage","volume":"4","author":"Dekel","year":"2004","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0095","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1152\/japplphysiol.00404.2009","article-title":"Hormone therapy attenuates exercise-induced skeletal muscle damage in postmenopausal women","volume":"107","author":"Dieli-Conwright","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0100","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1002\/art.21303","article-title":"Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy","volume":"52","author":"Fall","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0105","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.174.9.5324","article-title":"Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis","volume":"174","author":"Feferman","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0110","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/j.1743-6109.2009.01282.x","article-title":"Estrogens regulate humans and rabbit epididymal contractility through the RhoA\/Rho-kinase pathway","volume":"6","author":"Fibbi","year":"2009","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0115","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/mus.10462","article-title":"Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies","volume":"28","author":"Figarella-Branger","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejcb.2011.09.011_bib0120","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00000658-198610000-00008","article-title":"Fetal allograft survival in immunocompetent recipients is age dependent and organ specific","volume":"204","author":"Foglia","year":"1986","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0125","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.4049\/jimmunol.180.3.1471","article-title":"IFN-gamma arms human dendritic cells to perform multiple effector functions","volume":"180","author":"Frasca","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0130","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar2139","article-title":"Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies","volume":"9","author":"Grundtman","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0135","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.193.8.975","article-title":"Donor-derived IP-10 initiates development of acute allograft rejection","volume":"193","author":"Hancock","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2005.02143.x","article-title":"The intriguing biology of the tumour necrosis factor\/tumour necrosis factor receptor superfamily: players, rules and the games","volume":"115","author":"Hehlgans","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.ejcb.2011.09.011_bib0145","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.4049\/jimmunol.173.4.2815","article-title":"Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis","volume":"173","author":"Lande","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1568008053174723","article-title":"CXCR3-binding chemokines: novel multifunctional therapeutic targets","volume":"5","author":"Lazzeri","year":"2005","journal-title":"Curr. Drug Targets Immune Endocr. Metabol. Disord."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0155","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.autrev.2008.12.002","article-title":"CXCL10 and autoimmune diseases","volume":"8","author":"Lee","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0160","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-3083.1995.tb03587.x","article-title":"Local T-cell proliferation and differentiation in inflammatory myopathies","volume":"41","author":"Lindberg","year":"1995","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0165","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2796.2010.02334.x","article-title":"Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies?","volume":"269","author":"Loell","year":"2011","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-5728(95)00122-0","article-title":"Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls","volume":"63","author":"Lundberg","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0175","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s004150050087","article-title":"Inflammatory myopathies and systemic disorders: a review of immunopathogenetic mechanisms and clinical features","volume":"244","author":"Mantegazza","year":"1997","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0180","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2249.1998.00664.x","article-title":"A variety of cytokines and immunologically relevant surface are expressed by normal human skeletal muscle cells under proinflammatory stimuli","volume":"113","author":"Nagaraju","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0185","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coph.2008.02.005","article-title":"Skeletal muscle as an immunogenic organ","volume":"8","author":"Nielsen","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0190","first-page":"940","article-title":"Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis","volume":"27","author":"Nyberg","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-5728(03)00218-2","article-title":"Expression of IFN-gamma-inducible chemokines in inclusion body myositis","volume":"141","author":"Raju","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.it.2004.02.006","article-title":"CXC chemokines the regulatory link between inflammation and angiogenesis","volume":"25","author":"Romagnani","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0205","first-page":"195","article-title":"Expression of IP-10\/CXCL10 and MIG\/CXCL9 in the thyroid and increased serum levels of IP-10\/CXCL10 in the serum of subjects with recent onset Graves\u2019disease","volume":"161","author":"Romagnani","year":"2002","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0210","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1210\/jc.2004-1062","article-title":"Elevated serum interferon-gamma-inducible chemokine-10\/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines","volume":"90","author":"Rotondi","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0215","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/er.2006-0044","article-title":"Role of chemokines in endocrine autoimmune diseases","volume":"28","author":"Rotondi","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0220","first-page":"914","article-title":"Comparison between VDR analogs and current immunosuppressive drugs in relation to CXCL10 secretion by human renal tubular cells","volume":"23","author":"Sagrinati","year":"2010","journal-title":"Transpl. Int."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0225","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.4049\/jimmunol.169.5.2685","article-title":"Targeting the function of IFN-\u03b3-inducible protein 10 suppresses ongoing adjuvant arthritis","volume":"169","author":"Salomon","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0230","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/brain\/awn053","article-title":"Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle","volume":"131","author":"Schmidt","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.ejcb.2011.09.011_bib0235","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneuroim.2008.06.012","article-title":"Human myoblasts modulate the function of antigen-presenting cells","volume":"200","author":"Schwab","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/cimm.2000.1706","article-title":"Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis","volume":"205","author":"Suvannavejh","year":"2000","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0245","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/rheumatology\/keq151","article-title":"Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand","volume":"49","author":"Szodoray","year":"2010","journal-title":"Rheumatology (Oxford, U.K.)"},{"key":"10.1016\/j.ejcb.2011.09.011_bib0250","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/ard.2008.095984","article-title":"Chemokines and dendritic cells in inflammatory myopathies, Ann","volume":"68","author":"Tournadre","year":"2009","journal-title":"Rheum. Dis."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0255","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jbspin.2010.04.007","article-title":"Treatment of inflammatory muscle disease in adults","volume":"77","author":"Tournadre","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ejcb.2011.09.011_bib0260","doi-asserted-by":"crossref","first-page":"24286","DOI":"10.1074\/jbc.271.39.24286","article-title":"Interferon\u03b3-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response","volume":"271","author":"Wang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0265","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2005.05.003","article-title":"Immunobiology of muscle: advances in understanding an immunological microenvironment","volume":"26","author":"Wiendl","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0270","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.nurt.2008.08.008","article-title":"Idiopathic inflammatory myopathies: current and future therapeutic options","volume":"5","author":"Wiendl","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejcb.2011.09.011_bib0275","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/art.1780330713","article-title":"Interleukin-1 alpha, interleukin-2, and soluble interleukin-2 receptors in polymyositis","volume":"33","author":"Wolf","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0280","doi-asserted-by":"crossref","first-page":"E207","DOI":"10.2527\/jas.2007-0473","article-title":"Defining the transcriptional signature of skeletal muscle stem cells","volume":"86","author":"Yablonka-Reuveni","year":"2008","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.ejcb.2011.09.011_bib0285","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"}],"container-title":["European Journal of Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171933511001944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171933511001944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T17:14:19Z","timestamp":1759252459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171933511001944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0171933511001944"],"URL":"https:\/\/doi.org\/10.1016\/j.ejcb.2011.09.011","relation":{},"ISSN":["0171-9335"],"issn-type":[{"value":"0171-9335","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejcb.2011.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}